IO Biotech Inc (IOBT) — Financial Flexibility Index
IO Biotech Inc (IOBT) has a Financial Flexibility Index of -0.47x as of September 2025. Free cash flow of $-18.47 Million (operating CF $-18.48 Million minus capex $4.00K) represents 0% of total liabilities ($39.05 Million). Check IOBT strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
IO Biotech Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for IO Biotech Inc across 6 annual periods. See IOBT net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for IO Biotech Inc (2019–2024)
Year-by-year free cash flow to debt coverage for IO Biotech Inc. For the full company profile including market capitalisation, see IO Biotech Inc (IOBT) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.98x | $-82.30 Million | $-82.35 Million | $20.68 Million | ▲ +2.2% |
| 2023 | -4.07x | $-71.41 Million | $-71.74 Million | $17.56 Million | ▲ +10.8% |
| 2022 | -4.56x | $-59.04 Million | $-59.73 Million | $12.95 Million | ▼ -16.7% |
| 2021 | -3.91x | $-40.49 Million | $-40.65 Million | $10.36 Million | ▼ -21.6% |
| 2020 | -3.21x | $-9.80 Million | $-9.96 Million | $3.05 Million | ▼ -300.7% |
| 2019 | -0.80x | $-8.74 Million | $-8.89 Million | $10.89 Million | — |